Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics | Journal of Medicinal Chemistry
![Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics | Journal of Medicinal Chemistry Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c01312/asset/images/large/jm0c01312_0004.jpeg)
Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics | Journal of Medicinal Chemistry
![Diagnostics | Free Full-Text | Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients Diagnostics | Free Full-Text | Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients](https://pub.mdpi-res.com/diagnostics/diagnostics-10-00902/article_deploy/html/images/diagnostics-10-00902-g001.png?1604543361)
Diagnostics | Free Full-Text | Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients
![Robenidine Analogues Are Potent Antimalarials in Drug-Resistant Plasmodium falciparum | ACS Infectious Diseases Robenidine Analogues Are Potent Antimalarials in Drug-Resistant Plasmodium falciparum | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.1c00001/asset/images/large/id1c00001_0005.jpeg)
Robenidine Analogues Are Potent Antimalarials in Drug-Resistant Plasmodium falciparum | ACS Infectious Diseases
![Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. - Abstract - Europe PMC Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8143037/bin/nihms-1661620-f0008.jpg)
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. - Abstract - Europe PMC
![Selective Killing of Cancer Cells by Nonplanar Aromatic Hydrocarbon‐Induced DNA Damage - Zhou - 2019 - Advanced Science - Wiley Online Library Selective Killing of Cancer Cells by Nonplanar Aromatic Hydrocarbon‐Induced DNA Damage - Zhou - 2019 - Advanced Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/15858fe3-d6c1-4dae-8dd3-5b1b67c20c0f/advs1350-fig-0002-m.jpg)
Selective Killing of Cancer Cells by Nonplanar Aromatic Hydrocarbon‐Induced DNA Damage - Zhou - 2019 - Advanced Science - Wiley Online Library
Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy | Journal of Medicinal Chemistry
![Molecules | Free Full-Text | Development of a New Positron Emission Tomography Tracer for Targeting Tumor Angiogenesis: Synthesis, Small Animal Imaging, and Radiation Dosimetry Molecules | Free Full-Text | Development of a New Positron Emission Tomography Tracer for Targeting Tumor Angiogenesis: Synthesis, Small Animal Imaging, and Radiation Dosimetry](https://www.mdpi.com/molecules/molecules-18-05594/article_deploy/html/images/molecules-18-05594-g002.png)